Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort
There were independent and dose-response relationships between the novel systemic inflammation biomarkers and CVD outcomes. Addition of the inflammation biomarkers including novel inflammation biomarkers showed improved discrimination of the traditional risk prediction model. With accumulated evidence, these biomarkers should be considered for inclusion in risk tools and prevention.
Authors
- Jill P. Pell (ORCID: https://orcid.org/0000-0002-8898-7035)
- Carlos Celis‐Morales (ORCID: https://orcid.org/0000-0003-2612-3917)
- Frederick K. Ho (ORCID: https://orcid.org/0000-0001-7190-9025)
- Pei Qin
Institutions
- Catholic University of the Maule (CL)
- Guangzhou Development Zone Hospital (CN)
- University of Glasgow (GB)
- Arturo Prat University (CL)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1186/s12933-025-02721-9
- Citations
- 33
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 34.50